39th EDRN Steering Committee Main Agenda (Draft)

39th EDRN Steering Committee Meeting

Renaissance Seattle Hotel

Tuesday-Thursday, November 8-10, 2022

Draft Agenda

 

Tuesday, November 8, 2022

 

8:00 a.m. – 8:10 a.m. Welcome and Opening of the Steering Committee Meeting
o   Ziding Feng, PhD, Fred Hutchinson Cancer Center
o   Joshua LaBaer, MD, PhD, Arizona State University/The Biodesign Institute
8:10 a.m. – 8:30 a.m. Overview of the EDRN
o   Philip Castle, PhD, MPH, Director, Division of Cancer Prevention, National Cancer Institute
o   Sudhir Srivastava, PhD, MPH, National Cancer Institute
8:30 a.m. – 10:20 a.m. Presentations by Lung Biomarker Characterization Centers (BCCs) and Clinical Validation Centers (CVCs)
8:30 a.m. – 8:50 a.m. Title TBD
o   James Herman, MD, University of Pittsburgh Cancer Institute
o   Tza-Huei (Jeff) Wang, PhD, Johns Hopkins Whiting School of Engineering
o   Sanford Stass, MD, University of Maryland School of Medicine
8:50 a.m. – 9:10 a.m. Title TBD
o   Marc E. Lenburg, PhD, Boston University
o   Steven Dubinett, MD, University of California, Los Angeles
o   Jennifer Beane-Abel, PhD, Boston University
o   William Hsu, PhD, UCLA School of Engineering
9:10 a.m. – 9:30 a.m. Title TBD
o   Eric L Grogan, MD, Vanderbilt University Medical Center
o   Stephen Deppen, PhD, Vanderbilt University Medical Center
9:30 a.m. – 9:50 a.m. Title TBD
Sam Hanash, PhD, The University of Texas MD Anderson Cancer Center
9:50 a.m. – 10:20 a.m. Discussion: Identifying Opportunities for Collaboration
10:20 a.m. – 10:40 a.m. Break
10:40 a.m. – 11:50 a.m. Presentations by Prostate Biomarker Characterization Centers (BCCs)
10:40 a.m. – 11:00 a.m. Title TBD
o   Arul Chinnaiyan, MD, University of Michigan
o   Jeffrey Tosoian, MD, Vanderbilt University
11:00 a.m. – 11:20 a.m. Title TBD
o   Oliver John Semmes, PhD, Eastern Virginia Medical School
o   Paul Boutros, PhD, University of California, Los Angeles
o   Thomas Kislinger, PhD, University Health Network, University of Toronto
11:20 a.m. – 11:50 a.m. Discussion: Identifying Opportunities for Collaboration
11:50 a.m. – 12:30 p.m. Lunch (On Your Own)
12:30 p.m. – 2:20 p.m. Presentations by Breast and Ovarian Biomarker Characterization Centers (BCCs) and Clinical Validation Centers (CVCs)
12:30 p.m. – 12:50 p.m. Title TBD
o   Steven Skates, PhD, Massachusetts General Hospital
o   Abhijit Patel, PhD, Yale University
12:50 p.m. – 1:10 p.m. Title TBD
o   Zhen Zhang, PhD, Johns Hopkins University School of Medicine
o   Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine
1:10 p.m. – 1:30 p.m. Title TBD (Include Lung?)
o   Josh LaBaer, MD, PhD, Arizona State University/The Biodesign Institute
o   Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
1:30 p.m. – 1:50 p.m. Title TBD
o   Christopher Li, MD, PhD, Fred Hutchinson Cancer Center
o   Savannah Partridge, PhD, University of Washington
1:50 p.m. – 2:20 p.m. Discussion: Identifying Opportunities for Collaboration
2:20 p.m. – 2:40 p.m. Presentation by the DMCC
o   Ziding Feng, PhD, Fred Hutchinson Cancer Center
o   Ruth Etzioni, PhD, Fred Hutchinson Cancer Center
o   Yingye Zheng PhD, Fred Hutchinson Cancer Center
2:40 p.m. – 2:50 p.m. Q&A
2:50 p.m. – 3:10 p.m. Break
3:10 p.m. – 5:10 p.m. Data Sharing Policy Subcommittee Meeting and Informatics Subcommittee Meeting
5:00 p.m. Main Steering Committee Adjourn for the Day
5:30 p.m. - 7:00 p.m. EDRN Statistical Working Group Meeting (working meeting over dinner)
5:30 p.m. - 7:00 p.m. EDRN Reference Set Working Group (working meeting over dinner)








                                          

Wednesday, November 9, 2022

 

8:00 a.m. – 10:30 a.m. Presentations by GI Biomarker Characterization Centers (BCCs) and Clinical Validation Centers (CVCs)
8:00 a.m. – 8:20 a.m. Title TBD
o   Robert Bresalier, MD, The University of Texas MD Anderson Cancer Center
o   Sapna Syngal, MD, Dana-Farber Cancer Institute
8:20 a.m. – 8:40 a.m. Title TBD
o   Robert E. Schoen, MD, University of Pittsburgh
o   Cristian Tomasetti, MD, City of Hope
8:40 a.m. – 9:00 a.m. Title TBD
o   William Grady, MD, Fred Hutchinson Cancer Center
o   Cecilia Yeung, MD, Fred Hutchinson Cancer Center
9:00 a.m. – 9:20 a.m. Title TBD
o   Sanford Markowitz, MD, Case Western Reserve University
o   Joseph Willis, MD, Case Western Reserve University
o   Amit Chak, MD, UH Cleveland Medical Center
9:20 a.m. – 9:40 a.m. Title TBD
o   Amit Singal, MD, The University of Texas Southwestern
o   Fasiha Kanwal, MD, Baylor College of Medicine
o   Jorge Marrero, MD, University of Pennsylvania
o   Neehar Parikh, MD, University of Michigan
9:40 a.m. – 10:00 a.m. Title TBD
Anirban Maitra, MD, The University of Texas MD Anderson
10:00 a.m. – 10:30 a.m. Discussion: Identifying Opportunities for Collaboration
10:30 a.m. – 10:50 a.m. Break
10:50 a.m. – 12:30 p.m. Presentations by Early-Stage Investigators
17 x 5 min presentations (one investigator per center)
12:30 p.m. – 1:30 p.m. Lunch (On Your Own)
1:30 p.m.  –  5:00 p.m. Collaborative Group Meetings (closed session)
5:00 p.m. Adjourn for the Day



             

Thursday, November 10, 2022

 

8:00 a.m. – 10:40 a.m. Report from Collaborative Group Meetings
8:00 a.m. – 8:20 a.m. GI Report
8:20 a.m. – 8:40 a.m. GI Panel Discussion
8:40 a.m. – 9:00 a.m. Breast & Ovarian Report
9:00 a.m. – 9:20 a.m. Breast & Ovarian Panel Discussion
9:20 a.m. – 9:40 a.m. Lung Report
9:40 a.m. – 10:00 a.m. Lung Panel Discussion
10:00 a.m. – 10:20 a.m. Prostate Report
10:20 a.m. – 10:40 a.m. Prostate Panel Discussion
10:40 a.m. Closing Remarks/Steering Committee Meeting Adjourned
11:00 a.m. – 1:00 p.m. EDRN Executive Committee Meeting (closed session)